Golden Cross Stocks — Valuation View · Pharmaceutical Preparations
16 stocks match the Golden Cross Stocks screen. Stocks whose 50-day moving average has just crossed above their 200-day — a classic bullish trend signal. Valuation columns. Filtered to Pharmaceutical Preparations. Updated
Filters2
1–16 of 16
| ONC | Beone Medicines Ltd. | $535.9B | 817.25 | 87.43 | 103.57 | 105.11 | — | 362.54 | +0.23% | 14K |
| REGN | Regeneron Pharmaceuticals | $87.2B | 20.15 | 5.61 | 2.75 | 35.52 | 0.4% | 843.50 | -1.02% | 28K |
| ZYME | Zymeworks Inc. | $2.1B | -14.14 | — | 26.39 | 11.82 | — | 29.89 | -3.70% | 26K |
| HROW | Harrow, Inc. | $1.4B | -38.55 | 5.21 | 94.41 | 17.11 | — | 38.28 | -1.86% | 22K |
| JANX | Janux Therapeutics, Inc. | $1.2B | -11.82 | — | 1.31 | 43.66 | — | 19.83 | +0.71% | 72K |
| GERN | Geron Corp | $967M | -14.30 | 4079.84 | 4.42 | 15.44 | — | 1.50 | -5.35% | 1.3M |
| ARCT | Arcturus Therapeutics Holdings Inc. | $442M | -4.74 | — | 2.57 | 2.31 | — | 15.56 | -7.07% | 41K |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $222M | -2.17 | — | 2.17 | 9.48 | — | 11.46 | -0.22% | 29K |
| LGVN | Longeveron Inc. | $186M | -7.91 | 156.48 | 17.86 | 18.43 | — | 6.61 | -3.22% | 973 |
| BMEA | Biomea Fusion, Inc. | $138M | -4.25 | — | 11.41 | 3.98 | — | 1.91 | -1.04% | 35K |
| ANIX | Anixa Biosciences Inc | $106M | -10.18 | 503.25 | 7.30 | 75.60 | — | 3.04 | -2.88% | 4K |
| CDT | CDT Equity Inc. | $550669 | -0.01 | — | 0.01 | 0.74 | — | 0.70 | -23.73% | 10K |
| CMMB | Chemomab Therapeutics Ltd. | — | — | — | — | — | — | 2.82 | +3.30% | 3K |
| GLMD | Galmed Pharmaceuticals Ltd. | — | — | — | — | — | — | 4.01 | -1.72% | 229 |
| PRQR | ProQR Therapeutics N.V. | — | — | — | — | — | — | 2.08 | -3.48% | 43K |
| GMAB | Genmab A/S | — | — | — | — | — | — | 34.41 | +0.56% | 66K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.